CURCUMIN NANODELIVERY EFFECTS ON MK-801 INDUCED SCHIZOPHRENIA-LIKE BEHAVIORS

• Marina Picó-Gallardo,
• Susana Bulnes,
• Naiara Ortuzar,
• Andrea Vaquero-Rodríguez,
• José Vicente Lafuente,
• Harkaitz Bengoetxea

Affiliations

Marina Picó-Gallardo

University of the Basque Country (UPV/EHU), Neurosciences, Leioa, Spain

Susana Bulnes

University of the Basque Country (UPV/EHU), Neurosciences, Leioa, Spain; Biocruces Health Research Institute, Neurodegenerative Disease Group, Barakaldo, Spain

Naiara Ortuzar

University of the Basque Country (UPV/EHU), Neurosciences, Leioa, Spain; Biocruces Health Research Institute, Neurodegenerative Disease Group, Barakaldo, Spain

Andrea Vaquero-Rodríguez

University of the Basque Country (UPV/EHU), Neurosciences, Leioa, Spain; Biocruces Health Research Institute, Neurodegenerative Disease Group, Barakaldo, Spain

José Vicente Lafuente

University of the Basque Country (UPV/EHU), Neurosciences, Leioa, Spain; Biocruces Health Research Institute, Neurodegenerative Disease Group, Barakaldo, Spain

Harkaitz Bengoetxea

University of the Basque Country (UPV/EHU), Neurosciences, Leioa, Spain; Biocruces Health Research Institute, Neurodegenerative Disease Group, Barakaldo, Spain